Article (Scientific journals)
Révolution thérapeutique dans l’insuffisance cardiaque.
ANCION, Arnaud; NGUYEN TRUNG, Mai-Linh; Tridetti, J et al.
2020In Revue Médicale de Liège, 75 (5-6), p. 304-309
Editorial Reviewed verified by ORBi
 

Files


Full Text
20200506_07.pdf
Author postprint (723.49 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Aminobutyrates; Angiotensin Receptor Antagonists; Tetrazoles; Heart Failure/therapy; Hospitalization; Humans; Sacubitril/valsartan; Treatment; Heart Failure
Abstract :
[en] The introduction of basic treatment for heart failure dates to the late 1990s. Since that time, apart from a few new developments reserved for selected patients, there has been little progress. During these years, the epidemiology of the disease has evolved. The number of patients is constantly increasing and the prognosis is often darker than most oncological pathologies. With the arrival of the sacubitril/valsartan combination, Entresto®, a new therapeutic class has emerged. It has shown a significant reduction in mortality and hospitalizations for heart failure. The additional benefits to be expected from this molecule are still being evaluated. Significant positive remodeling seems to be a reality for many patients. This spectacular advance, however, is not the final solution. In addition, patients with preserved heart failure do not seem to benefit the same from this molecule. Other advances are being assessed. Sacubitril/valsartan is the first revolution, perhaps, in a long series.
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
ANCION, Arnaud  ;  Centre Hospitalier Universitaire de Liège - CHU > > Service de cardiologie
NGUYEN TRUNG, Mai-Linh  ;  Centre Hospitalier Universitaire de Liège - CHU > > Service de cardiologie
Tridetti, J;  Service de Cardiologie, CHU Liège, Belgique.
LANCELLOTTI, Patrizio  ;  Centre Hospitalier Universitaire de Liège - CHU > > Service de cardiologie
Language :
French
Title :
Révolution thérapeutique dans l’insuffisance cardiaque.
Alternative titles :
[en] Therapeutic revolution in heart failure.
Publication date :
May 2020
Journal title :
Revue Médicale de Liège
ISSN :
0370-629X
eISSN :
2566-1566
Publisher :
Université de Liège. Revue Médicale de Liège, Liège, Be
Volume :
75
Issue :
5-6
Pages :
304-309
Peer reviewed :
Editorial Reviewed verified by ORBi
Available on ORBi :
since 25 May 2022

Statistics


Number of views
86 (5 by ULiège)
Number of downloads
93 (4 by ULiège)

Scopus citations®
 
2
Scopus citations®
without self-citations
0

Bibliography


Similar publications



Contact ORBi